Filing Flows › Vanda Pharmaceuticals (VNDA) › Recalls, complaints & regulation
Vanda Pharmaceuticals (VNDA): clinical trials
Vanda Pharmaceuticals (VNDA) beyond its filings: 18 active clinical trials.
Vanda Pharmaceuticals' latest quarter
Vanda Pharmaceuticals, Q3 2026: revenue $69.8M (+24% year over year), operating margin -33.7%, net loss $22.6M, operating cash flow −$28.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Vanda Pharmaceuticals have?
18 active studies on ClinicalTrials.gov, 10 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.